125 related articles for article (PubMed ID: 8092887)
21. [Metastasis in patients with uterine tube carcinoma].
Karag'ozov A; Chakalova G; Gancheva A
Akush Ginekol (Sofiia); 1990; 29(4):45-8. PubMed ID: 2267980
[TBL] [Abstract][Full Text] [Related]
22. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
[TBL] [Abstract][Full Text] [Related]
23. Carcinoma of the Fallopian tube treated with a combination of surgery and cytotoxic chemotherapy. Case report.
Guthrie D; Cohen S
Br J Obstet Gynaecol; 1981 Oct; 88(10):1051-3. PubMed ID: 7284284
[No Abstract] [Full Text] [Related]
24. Preoperative diagnosis of early fallopian tube carcinoma.
Elsandabesee D; Scott-Barrett S; Crocker SG
J Obstet Gynaecol; 2007 Jan; 27(1):99-100. PubMed ID: 17365483
[No Abstract] [Full Text] [Related]
25. Rare primary fallopian tube carcinoma; a gynaecologist's dilemma.
Chaudhry S; Hussain R; Zuberi MM; Zaidi Z
J Pak Med Assoc; 2016 Jan; 66(1):107-10. PubMed ID: 26712194
[TBL] [Abstract][Full Text] [Related]
26. Serial measurement of CA 125 in patients with primary carcinoma of the fallopian tube.
Tokunaga T; Miyazaki K; Matsuyama S; Okamura H
Gynecol Oncol; 1990 Mar; 36(3):335-7. PubMed ID: 2318441
[TBL] [Abstract][Full Text] [Related]
27. Preoperative diagnosis of the primary fallopian tube carcinoma by three-dimensional static and power Doppler sonography.
Kurjak A; Kupesic S; Jacobs I
Ultrasound Obstet Gynecol; 2000 Mar; 15(3):246-51. PubMed ID: 10846782
[TBL] [Abstract][Full Text] [Related]
28. Primary fallopian tube carcinoma--a retrospective survey of 51 cases. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.
Klein M; Rosen A; Graf A; Lahousen M; Kucera H; Pakisch B; Vavra N; Beck A
Arch Gynecol Obstet; 1994; 255(3):141-6. PubMed ID: 7979566
[TBL] [Abstract][Full Text] [Related]
29. [Early stage fallopian tube carcinoma--diagnosis, staging and treatment].
Ben-Ami I; Halperin R; Herman A; Schneider D
Harefuah; 2004 Nov; 143(11):790-3, 839. PubMed ID: 15603266
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up.
Xourafas D; Tavakkoli A; Clancy TE; Ashley SW
Surgery; 2015 Mar; 157(3):473-83. PubMed ID: 25596773
[TBL] [Abstract][Full Text] [Related]
31. A 15-year overview of management and prognosis in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.
Rosen AC; Ausch C; Hafner E; Klein M; Lahousen M; Graf AH; Reiner A
Eur J Cancer; 1998 Oct; 34(11):1725-9. PubMed ID: 9893660
[TBL] [Abstract][Full Text] [Related]
32. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
[TBL] [Abstract][Full Text] [Related]
33. Primary fallopian tube carcinoma: clinicopathological analysis of 12 cases.
Ou YC; Huang HY; Huang CC; Changchien CC; Tseng CW; Lin H
Taiwan J Obstet Gynecol; 2011 Jun; 50(2):141-4. PubMed ID: 21791297
[TBL] [Abstract][Full Text] [Related]
34. Adenocarcinoma of the fallopian tube.
Amendola BE; LaRouere J; Amendola MA; McClatchey KD; Han IH; Morley GW
Surg Gynecol Obstet; 1983 Sep; 157(3):223-7. PubMed ID: 6612570
[TBL] [Abstract][Full Text] [Related]
35. Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?
Rocconi RP; Sullivan P; Long B; Blaize M; Brown J; Arbuckle J; Bevis K; Estes JM; Reed E; Finan MA
Int J Gynecol Cancer; 2012 Jun; 22(5):786-91. PubMed ID: 22552832
[TBL] [Abstract][Full Text] [Related]
36. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
Li QL; Wang CJ; Qi P; Zhang YX
Clin Transl Oncol; 2017 Oct; 19(10):1260-1267. PubMed ID: 28444641
[TBL] [Abstract][Full Text] [Related]
37. [Primary urothelial carcinoma of the fallopian tube].
Rabczyński J; Kochman A; Hudziec P
Przegl Lek; 1998; 55(11):572-5. PubMed ID: 10216369
[TBL] [Abstract][Full Text] [Related]
38. Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.
Usami T; Kato K; Taniguchi T; Abe A; Nomura H; Yamamoto A; Matoda M; Okamoto S; Kondo E; Omatsu K; Kawamata Y; Takeshima N
Int J Gynecol Cancer; 2014 Jul; 24(6):991-6. PubMed ID: 24905612
[TBL] [Abstract][Full Text] [Related]
39. [The clinicopathological features and risk factors of recurrence in patients with mucinous borderline ovarian tumors].
Sun L; Song Y; Li N; Yuan GW; Sun YC; Li N; Ma SK; Zhang X; Wu LY
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):589-594. PubMed ID: 28835081
[No Abstract] [Full Text] [Related]
40. Surgery and radiotherapy in the treatment of primary carcinoma of the Fallopian tube--report of 18 cases.
Wong WS; Tindall VR; Wagstaff J; Bramwell V; Crowther D
Aust N Z J Obstet Gynaecol; 1985 Aug; 25(3):211-5. PubMed ID: 3866560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
